Skip to main content
OpenTrials

Clinical trial condition

Transthyretin Amyloidosis

Explore clinical trials studying Transthyretin Amyloidosis. Study availability and eligibility vary by location and protocol.

32 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Transthyretin Amyloidosis trial results

Recruiting

Long-term Safety of Eplontersen Treated aTTR Patients and in Liver Transplant and Severely Hepatic Impaired Subpopulations

NCT07654855

Conditions
Amyloidosis, Hereditary, Transthyretin-Related, Transthyretin Amyloidosis, Transthyretin Amyloidosis With Cardiomyopathy, +1 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Vancouver, British Columbia, Canada
  • Research Site Beijing, China
  • Research Site Hanover, Germany
View Trial Details
Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

NCT06563895

Conditions
Alzheimer Disease, Amyloid Cardiomyopathy, Amyloid Neuropathies, +26 more
Locations
  • University of California, San Diego (UCSD) - Medical Center La Jolla, California, United States
  • University of California, Los Angeles (UCLA) - David Geffen School of Medicine Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
  • Stanford University Stanford, California, United States
View all 104 locations
View Trial Details

Related conditions